Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-06-04

FDA Approved: CEVIMELINE HYDROCHLORIDE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved Rising Pharma Holdings' cevimeline hydrochloride as an Original Application (ANDA 203775), establishing a generic version of the treatment for xero…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • cevimeline hydrochloride (cevimeline hydrochloride)

Snippet

ORIG AP for CEVIMELINE HYDROCHLORIDE (CEVIMELINE HYDROCHLORIDE)